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Abstract
Background: ADPH oxidase-derived reactive oxygen species (ROS) play important roles in redox homeostasis and signal
transduction in endothelial cells (ECs). We previously demonstrated that c-Src plays a key role in VEGF-induced, ROS-
dependent selective activation of PI3K-Akt but not PLCc-1-ERK1/2 signaling pathways. The aim of the present study was to
understand how VEGFR-2-c-Src signaling axis ‘senses’ NADPH oxidase-derived ROS levels and couples VEGF activation of
c-Src to the redox state of ECs.
Methodology/Principal Findings: Using biotinylated probe that detects oxidation of cysteine thiol (cys-OH) in intracellular
proteins, we demonstrate that VEGF induced oxidative modification in c-Src and VEGFR-2, and that reduction in ROS levels
using siRNA against p47
phox subunit of Rac1-dependent NADPH oxidase inhibited this phenomenon. Co-immunoprecip-
itation studies using human coronary artery ECs (HCAEC) showed that VEGF-induced ROS-dependent interaction between
VEGFR-2 and c-Src correlated with their thiol oxidation status. Immunofluorescence studies using antibodies against
internalized VEGFR-2 and c-Src demonstrated that VEGF-induced subcellular co-localization of these tyrosine kinases were
also dependent on NADPH oxidsase-derived ROS.
Conclusion/Significance: These results demonstrate that VEGF induces cysteine oxidation in VEGFR-2 and c-Src in an
NADPH oxidase-derived ROS-dependent manner, suggesting that VEGFR-2 and c-Src can ‘sense’ redox levels in ECs. The
data also suggest that thiol oxidation status of VEGFR-2 and c-Src correlates with their ability to physically interact with each
other and c-Src activation. Taken together, these findings suggest that prior to activating downstream c-Src-PI3K-Akt
signaling pathway, VEGFR-2-c-Src axis requires an NADPH oxidase-derived ROS threshold in ECs.
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INTRODUCTION
Reactive oxygen species (ROS) are oxidizing molecules that have
unpaired electrons,such as superoxide(O2
?-), hydroxyl anion (HO
?),
and nitric oxide (NO
?), or that may not have free electrons but
possess oxidizing ability, such as hydrogen peroxide (H2O2),
hypochlorous acid (HOCl), and peroxynitrite (ONOO
-). ROS are
often considered as harmful metabolic by-products and have
traditionally been implicated in the pathogenesis of cardiovascular
diseases including hypertension, atherosclerosis, diabetic vasculo-
pathy, and heart failure [1,2,3]. However, ROS, at physiological
concentration, have recently been shown to be essential for signal
transduction in vascular cells, including endothelial cells (ECs)
[4,5,6,7,8,9,10,11,12,13]. We and others have reported Rac1-
dependent NADPH oxidase as a major source of superoxide in ECs
and thus one of the important determinants of the redox content of
the endothelium [14,15,16,17]. Rac1-dependent NADPH oxidase
consists of two membrane-bound components, gp91
phox (also
known as Nox2) and p22
phox, and several cytosolic regulatory
subunits, including p47
phox, p67
phox, and the small GTPase Rac1.
Upon agonist stimulation, NADPH oxidase transfers electrons from
NAD(P)H to molecular oxygen to form O2
?-. Recently, NADPH
oxidase-derived ROS have been implicated in EC proliferation,
migration, and angiogenesis [14,15,17].
Vascular endothelial growth factor (VEGF) is a potent EC-specific
mitogen and chemotactic factor that is involved in wound repair,
angiogenesis of ischemic tissue, tumor growth, microvascular
permeability, vascular protection, and hemostasis [18,19]. The VEGF
family of proteins binds to three major receptor-type tyrosine kinases,
Flt-1 (VEGF receptor-1), KDR/Flk-1 (VEGF receptor-2), and
VEGFR-3 [20,21]. VEGF activates a number of different intracel-
lular signaling pathways, including phospholipase Cc,p r o t e i nk i n a s e
C, mitogen-activated protein kinase (MAPK)/extracellular signal–
regulated kinase (ERK), non-receptor tyrosine kinase c-Src, and
phosphatidyl inositol 3-kinase (PI3K)/Akt/protein kinase B in ECs.
In 2000, we reported that VEGF induced Rac1-dependent
NADPH oxidase activity resulting in transient increase in ROS
levels, and that NADPH oxidase-derived ROS are essential for
proliferation and migration in ECs [15,22]. These findings were
supported by others in subsequent studies [16,17]. More recently, we
PLoS ONE | www.plosone.org 1 December 2011 | Volume 6 | Issue 12 | e28454reported that reduction in NADPH oxidase activity resulted in
inhibition of VEGF-induced activation of c-Src-PI3K-Akt-eNOS
(but not PLCc-1-ERK1/2) [23], reduction in NO synthesis and
coronary arteriolar vasodilatation [24]. These suggested that an ROS
threshold is required to selectively turn on c-Src-PI3K-Akt-eNOS by
VEGF in ECs, where c-Src appears to play a major role in
propagating signals from VEGFR-2 to downstream PI3K-Akt in a
redox-dependent manner [23]. However, the precise mechanisms of
signal transduction by which NADPH oxidase-derived ROS
modulate some (e.g. c-Src) but not all (e.g. PLCc-1-ERK1/2) post-
VEGFR-2 signaling pathways are not known. In non-endothelial
cells, transient inhibition of protein tyrosine phosphatases (PTPs) by
oxidation of their catalytic cysteine thiols (SH-group) has been
proposed to be the mechanism by which ROS help propagate
receptor tyrosine kinase (RTK) signaling [25,26,27]. For example,
ROS induced transient oxidation (sulfenic acid/cys-OH formation)
of the cysteine residue(s) in the PTP, SHP-2, in response to PDGF
that requires association with the PDGFR [25]. Recently, similar
mechanismshave been proposed for VEGF signaling in ECs [28,29],
suggesting that ROS-mediated transient inhibition of the PTPs (e.g.
PTP1B, SHP2, DEP-1) plays a permissive role in signal transduction
by VEGFR-2. Our findings that NADPH oxidase-derived ROS are
requiredforselectiveactivationofsomebutnotallsignalingpathways
downstream of VEGFR-2 [23] can not be explained by such
generalized effect of PTP inhibition on VEGFR-2. Rather, our data
suggested that VEGF-induced ROS were specifically required to
channel post-VEGFR-2 signal to c-Src [23], whereas VEGFR-2-
PLCc-1-ERK1/2 signaling was independent of ROS. However, the
molecular mechanisms by which ROS link VEGFR-2 with c-Src are
not known. The goal of this study was to understand how VEGFR-2-
c-Src signaling axis ‘senses’ ROS levels and couples VEGF activation
of c-Src to the redox state of the endothelium. Here, we present novel
findings that VEGF oxidizes cysteine thiol (cys-SH) in c-Src and
VEGFR-2 in HCAEC. We also demonstrate that VEGF-induced
oxidation of VEGFR-2, c-Src, and their intracellular interaction are
specifically dependent on NADPH oxidase-derived ROS.
RESULTS
NADPH oxidase-derived ROS are required for signal
propagation from VEGFR-2 to c-Src but not PLCc-1
We wanted to examine the role of NAPDH oxidase-derived
ROS on VEGF-induced activation of VEGFR-2 and c-Src. To
that end, total ROS levels were reduced by more than 50% in
HCAEC by inhibiting NADPH oxidase using siRNA against
p47
phox (si- p47
phox) [23]. Reduction in intracellular ROS in-
hibited VEGF-mediated phosphorylation of Akt but not ERK1/2
in HCAEC (Figure 1A upper panel, and Figure 1B), suggesting
that selective activation of some but not all VEGF signaling
pathways requires ROS. In order to identify the redox-sensitive
signaling intermediates that are upstream of Akt, we examined
phosphorylation of VEGFR-2, PLCc-1, and c-Src by VEGF in
NADPH oxidase-knockdown HCAECs. We observed that where-
as Y1175-VEGFR-2 (and total tyrosine, data not shown) and
PLCc-1 phosphorylation was not dependent on ROS (Figure 1B),
c-Src phosphorylation was significantly inhibited in NADPH
oxidase-knockdown HCAECs (Figure 1A lower panel). General-
ized reduction in ROS levels in HCAEC using diphenylamine
(DPI, 10 mM, for 30 mins) also resulted in selective inhibition of
VEGF-mediated activation of c-Src and Akt but not PLCc-1 or
ERK1/2 (data not shown). Together, these findings suggest that
ROS play a crucial role in selective propagation of signals from
VEGFR-2 to downstream c-Src-PI3K-Akt but not PLCc-1-
ERK1/2.
VEGF induces thiol oxidation of c-Src and VEGFR-2 in an
ROS-dependent manner
Since VEGF-induced activation of c-Src requires ROS in ECs
[23] and thiol oxidation of c-Src has been shown to be associated
with its kinase activity in non-endothelial cells [30], we examined
whether VEGF treatment induces oxidation of cysteine residues in
c-Src. To that end, we have utilized a modoified cysteinyl-labeling
assay that is highly sensitive to sulfenic acid intermediates (cys-
OH), which are formed initially during oxidative modification of
cysteine SH-group (Figure 2A). This three-step assay includes
alkylation of intracellular non-oxidized thiols, biotin-labeling of
transiently oxidized cysteine (cys-OH) residues, and pull down of
biotinylated proteins by streptavidin followed by Western blots.
Two-minute incubation with VEGF induced c-Src oxidation (by
8.26 0.68 fold) in HCAEC, whereas inhibition of NADPH
oxidase-derived ROS using si-p47
phox completely blocked thiol
oxidation of c-Src (Figure 2B–C). Similarly, ligand-induced thiol
oxidation of VEGFR-2 (4.86 0.74 fold) was also dependent on
NADPH oxidase-derived ROS (Figure 2B–C). These findings
suggest that VEGF induces oxidative modification in VEGFR-2
Figure1.VEGF-inducedactivationofc-Src,Akt,butnotVEGFR-2,PLCc-1andERK1/2requiresNADPHoxidase-derivedROS. (A) Protein
extracts from HCAEC transfected with control siRNA (Scram-si) or si-p47
phox were subject to Western blots as described in Materials and methods.
Serum-starved HCAEC were treated with VEGF (50 ng/ml) for the times indicated. Membranes were sequentially blotted, stripped and re-probed with
the phospho-specific antibodies as shown. Blots shown are representative of three independent experiments. (B) Same as in (A) except, the
membranes were probed for phosphorylation of Y1175 VEGFR-2, Y783 PLCc-1 and p42/44 ERK1/2. Anti-b-actin antibody was used as loading control.
doi:10.1371/journal.pone.0028454.g001
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for oxidation of these tyrosine kinases in HCAEC.
VEGF-induced c-Src-VEGFR-2 interaction requires NADPH
oxidase-derived ROS
VEGFR-2 is known to bind c-Src upon ligand stimulation [31].
Since VEGF induces activation and thiol oxidation of both c-Src
and VEGFR-2 (Figs. 1 and 2), we next wanted to examine whether
interaction between c-Src and VEGFR-2 was dependent on
NADPH oxidase-derived ROS. Co-immunoprecipitation assay
showed that VEGF induced binding of c-Src to VEGFR-2 in
HCAEC transfected with scrambled siRNA (Scram-si), whereas
reduction in ROS significantly inhibited interaction between c-Src
and VEGFR-2 in si-p47
phox-transfected HCAEC (Figure 3).
Immunofluorescence studies using antibody against internalized
VEGFR-2 and c-Src demonstrated that reduction in ROS
significantly reduced intracellular co-localization of these two
tyrosine kinases (Figure 4).Together, these findings suggest that
thiol oxidation of c-Src and VEGFR-2 may play an important role
in VEGF-induced interaction between c-Src and VEGFR-2.
Figure 2. c-Src and VEGFR-2 are oxidized in VEGF-treated HCAEC in the presence of NADPH oxidase-derived ROS. (A) Schematic
presentation depicting cysteinyl-labeling assay to determine oxidative modification in intracellular proteins. Non-oxidized protein thiols are
alkyalated by IAA, oxidized thiols are reduced back to SH-moiety by DTT and subsequently biotinylated by IAP. Biotinylated proteins are then pulled-
down by streptavidin-agarose followed by Western blots. (B) Upper panel: cysteinyl labeling assay to Identify thiol oxidation of proteins in VEGF-
treated (50 ng/ml for 2 mins) HCAEC lysates using biotinylated IAP probe. HCAEC were transfected with Scram-si or si-p47
phox as indicated. After cell
lysis in the presence of IAA followed by DTT treatment and IAP labeling, 1.5 mg biotinylated protein lysates were subject to immunoprecipitation
using Streptavidin-agarose beads and immunoblotted using anti-VEGFR-2 and anti-c-Src antibodies. Lower panel: Western blot for VEGFR-2 using
50 mg of parallel HCAEC lysates as loading control. (B) Quantitative analyses of oxidized VEGFR-2 (upper panel) and c-Src (lower panel). Bar graph
shows quantitative densitometric analysis of three independent cysteinyl labeling assays (as in A) using NIH J image (-fold change expressed in mean
6 S.E.M.). *p,0.05 was considered statistically significant.
doi:10.1371/journal.pone.0028454.g002
Figure 3. VEGF-induced interaction between VEGFR-2 and c-Src requires NADPH oxidase-derived ROS. (A) Co-immunoprecipitation
(co-IP) assay using 1.2 mg protein lysates of HCAEC that were transfected with Scram-si or si-p47
phox and treated without or with VEGF (50 ng/ml for
5 min). IP was carried out using anti-VEGFR-2 antibody followed by immunoblotting using anti-c-Src (upper panel) and anti-VEGFR-2 (lower panel)
antibodies. (B) Quantitative analyses of VEGFR-2-bound c-Src. Bar graphs show quantitative densitometric analysis of three independent experiments
using NIH image J (-fold change expressed in mean 6 S.E.M.). *p,0.05 was considered statistically significant.
doi:10.1371/journal.pone.0028454.g003
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The goal of the present study was to understand how VEGF
signaling ‘senses’ ROS levels and tailors activation of a specific
signaling pathway c-Src-PI3K-Akt, but not PLCc-1-ERK1/2, to
the redox state of the endothelium. Specifically, we have examined
whether NADPH oxidase-derived ROS are required to induce
oxidative modification in VEGFR-2 and c-Src by VEGF, and
whether VEGF-induced interaction between VEGFR-2 and c-Src
requires ROS. Using a biotinylated probe that binds proteins with
cysteine sulfenic acid (cys-OH) modification, we show for the first
time that VEGF induces thiol oxidation in VEGFR-2 and c-Src in
HCAEC. Our data also demonstrate that ROS-induced, cysteine-
thiol oxidation of the receptor (VEGFR-2) and the non-receptor (c-
Src) tyrosine kinase correlate with their subcellular co-localization
and physical interaction. These findings directly link endothelial
redox status to the activation of a selective VEGF signaling path-
way, namely c-Src-PI3K-Akt.
ROS act as second messengers by modulating protein functions
through oxidation of cysteine thiols. The effect of thiol oxidation
on the function of a protein is context-dependent. For example,
ROS transiently inhibited PTPs by oxidizing catalytic cysteine
thiol and thus allowed activation of signaling pathways down-
stream of PDGFR [25,27]. On the contrary, ROS-induced thiol
oxidation (and nitric oxide-mediated nitrosylation) at the C-
terminus cysteine residues of c-Src was shown to regulate activity
of the kinase in non-endothelial cells [32,33,34,35]. However, a
role for cysteine thiol oxidation in VEGF signaling pathways has
not been reported. The current study shows a novel thiol oxidation
mechanism by which NADPH oxidase-derived ROS may act to
channel post-VEGFR-2 signaling specifically to downstream c-Src,
and thus render c-Src-PI3K-Akt signaling ROS-dependent in ECs
(Figure 5). However, our data do not identify specific cysteine
residues that are oxidized by ROS in VEGFR-2 and c-Src.
Although there are reports of redox-sensitive cysteine residues in
the C-terminus of c-Src [32,33,34,35], redox-sensitive cysteine
residues in VEGFR-2 are not known. A sequence comparison
study revealed two conserved cysteine residues in the cytoplasmic
tail of VEGFR-2 among several species (Figure S1). Experiments
are being carried out to determine whether one or more of these
cysteine residues are oxidized by VEGF-induced ROS and
whether intermolecular cysteine disulfide bridge formation plays
a role in VEGFR-2-c-Src interaction in ECs. Disulfide bonds are
usually formed by oxidation of cysteine’s SH group as follows: 2
Cys-SH = Cys-S – S-Cys + 2H
+ + 2e
-. ROS including H2O2
oxidize cysteine residues in proteins to form this disulfide bond,
where sulfenic acid (Cys-OH) formation acts as an intermediate
product of oxidation [36].
It is interesting to note that although activation of PLCc-1 is not
ROS-dependent (Figure 1), VEGF induced thiol oxidation in
PLCc-1 in an NADPH oxidase-derived ROS-independent
manner (Figure S2). Together, these data suggest that other
sources of ROS may be involved in this phenomenon, thus
rendering VEGF-induced activation of PLCc-1-ERK1/2 signal-
ing independent of NADPH oxidase-derived ROS. Alternate
plausible explanation is that oxidation may not play significant role
in VEGF-induced activation of PLCc-1.
Upon activation, internalization and endocytic trafficking of
VEGFR-2 are critical for proper signal propagation in ECs
[28,37,38]. Our preliminary data demonstrated that, although
Figure 4. VEGF induces subcellular co-localization of c-Src and internalized VEGFR-2 in an ROS-dependent manner. HCAEC
transfected with control (Scram-si) (A) or si-p47
phox (B) were immunofluorescently double labeled for internalized VEGFR-2 (green) and c-Src (red).
VEGFR-2 on HCAEC was labeled with single chain E-tagged antibody (scFvA7, Fitzerald) as described in Materials and methods. After incubation with
VEGF (50 ng/ml for 10 min), in order to remove the antibody from the cell surface, cells were placed on ice and acid washed. In permeabilized and
fixed HCAEC, VEGFR-2 was detected with an AlexaFluor488-conjugated secondary antibody and is shown in green. c-Src was labeled with
AlexaFluor647-conjugated secondary antibody (red) and nuclei with DAPI (blue). (B) Bar graphs show image analysis for colocalization events using
the NIH Image J plugin (as described in Materials and methods). The graphs present the number of colocalization events normalized for the number
of total VEGFR-2–positive immunofluorescence signals. Values are the mean of three experiments 6 S.E.M., each containing numbers obtained from
five random fields. *p,0.05 was considered statistically significant.
doi:10.1371/journal.pone.0028454.g004
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cellular trafficking through early stage endosomes (EEA-1 positive)
was affected by NADPH oxidase inhibition (Figure S3). However,
this finding does not address the question whether ROS play any
role in the internalized receptor’s recycling to the membrane
(through endocytic pathway) and/or degradation. It is plausible
that redox-dependent endocytic trafficking of the receptor is a pre-
requisite for proper co-localization and interaction between
VEGFR-2 and c-Src in ECs. Further experiments are required
to address this question.
In summary, the data presented in this study demonstrate for
the first time that VEGF induces thiol oxidation in VEGFR-2 and
c-Src in an NADPH oxidase-derived ROS-dependent manner
(Figure 5). Subcellular localization and interaction between these
two tyrosine kinases are associated with their oxidation status.
Although interaction with c-Src was inhibited (Figure 3), phos-
phorylation and internalization (Figure1, Figure S2) of VEGFR-2
were not affected by reduction in ROS levels, suggesting that thiol
oxidation of the receptor may play a specific role in c-Src
activation. Further studies are required to elucidate the mecha-
nisms by which thiol oxidation mediates interaction between these
two tyrosine kinases and activation of downstream c-Src. Ex-
periments are now being carried out to examine the involvement
of the conserved cysteine residues in the cytoplasmic domain of
VEGFR-2 in this process. In order to determine functional sig-
nificance of these findings, in vivo studies are also undergoing to
detect in situ thiol oxidation in VEGFR-2 and c-Src in intact
vascular endothelium.
MATERIALS AND METHODS
Cell culture and reagents
Human coronary artery endothelial cells (HCAEC) were ob-
tained from Clonetics and grown in Endothelial Growth Medium-
2-MV (EGM-2-MV) BulletKit (Clonetics, San Diego, CA) at 37uC
and 5% CO2. Endothelial cells from passage 3 to 6 were used for
all experiments. Cells were serum starved in 0.5% fetal bovine
serum (FBS) for 16 h prior to treatment with 50 ng/mL human
VEGF-A165 (PeproTech Inc, Rocky Hill, NJ). For the detection of
internalized VEGFR-2 by immunofluorescence, anti–human
VEGFR-2 (single chain recombinant; clone scFvA7 with E tag;
RDI and Fitzgerald) was used. Rabbit polyclonal C-1158 (sc504;
Santa Cruz Biotechnology, Inc.) was used for Western blotting
detection of VEGFR-2. Antibodies to tyrosine-phosphorylated
VEGFR-2, phospho-Y1175, was from Cell Signaling. Antibody to
EEA-1 was goat polyclonal N-19 (sc-6415) from Santa Cruz
Biotechnology, Inc. Antibodies against phospho-S473-Akt, total
Akt, phospho-Y783-PLCc-1, phospho-p42/44 MAPK, phospho-
Y416-c-Src, and total c-Src were from Cell Signaling. Zeba desalt
spin columns (89889), IAA (35603), and IAP were from Thermo
Scientific (Pierce Biotechnology).
siRNA transfection
HCAEC were grown to 70–80% confluence in 6-cm plates and
transfectedwith100 nM ON-TARGETplus si-RNAagainstp47
phox
(Dharmacon, Lafayette, CO) or scrambled siRNA (Scram-si) in
Opti-MEM containing 10 mg/mL Lipofectin (Invitrogen, Carlsbad,
CA) for 5 h. The cells were then incubated in EGM-2-MV medium
for 24 h following serum starvation in endothelial basal medium
(EBM-2; Clonetics) containing 0.2% serum for 16 h prior to VEGF
treatment.
Western blotting
HCAEC were harvested for total protein and Western blots
were carried out as previously described [39]. Phospho-specific
antibodies against Y416-c-Src, Ser-473 Akt, PLCc-1, and ERK1/
2 were purchased from Cell Signaling (Beverly, MA). Anti-b-actin
antibodies were from Sigma. Western blots were performed using
cell extracts prepared from three independent experiments.
Cysteinyl labeling/thiol oxidation assay
Cysteinyl labeling assay, a three-step method in which reversibly
oxidized cysteine (Cys) residues are specifically biotinylated and
enriched to quantitatively measure thiol oxidation [27]. The steps
are: (i) the reduced/non-oxidized Cys residues are irreversibly
alkylated and excluded from the reaction by iodoacetic acid (IAA);
(ii) IAA-cleared lysates are then incubated with 1 mM DTT to
reduce the oxidized Cys residues (cyclic sulfenamide and sulfenic
acid forms of Cys), which were protected from alkylation in the
previous step, back to their thiolate states; and (iii) these thiol
residues (that were initially oxidized inside the cells and protected
from alkylation by IAA, but now are in the reduced state) are then
biotinylated with sulfhydryl-reactive iodoacetylpolyethylene oxide
(IAP, Thermo Scientific) probe (5 mM). The biotinylated proteins
are then enriched by using streptavidin-agarose beads and ana-
lyzed by Western blots using antibodies against proteins of interest.
The signal intensity of the biotinylated bands directly correspond
to the oxidation status of the cysteine residues of the proteins.
VEGFR-2 and c-Src were subsequently identified by immuno-
blotting with anti-VEGFR-2 and anti-c-Src antibodies (Cell
Signaling), respectively. The cell lysis buffer used contained the
following: 25 mM sodium acetate (pH 5.5), 1% Nonidet P-40,
150 mM NaCl, 10% (vol/vol) glycerol, 25 mg/ml aprotinin,
25 mg/ml leupeptin, supplemented with freshly prepared 10 mM
IAA, 100 mg/ml catalase, and superoxide dismutase. After 1 h at
room temperature to allow complete alkylation of free thiols, 1 mg
of cell lysate was loaded onto desalting columns that had been
equilibrated with IAA-free lysis buffer. Columns were centrifuged
at 2,0006g for 2 min at 4uC to remove IAA. The flow-through of
the desalting columns (IAA-cleared lysates) was then incubated
with 1 mM DTT for 30 min on a shaker at room temperature.
5 mM IAP (biotinylated probe) were added to bind reduced thiols,
and biotinylated proteins were pulled down using streptavidin–
agarose beads overnight at 4uC. The precipitated beads were
Figure 5. Proposed model: thiol oxidation may help propagate
signal transduction from VEGFR-2 to downstream c-Src. (A)
VEGF activation of VEGFR-2 and downstream PLCc-1-ERK1/2 signaling
pathway appears to be independent of ROS levels in ECs. (B) VEGF
induces NADPH oxidase-derived ROS, which in turn oxidizes VEGFR-2
and c-Src. Thiol oxidation of these two tyrosine kinases appears to
correlate with VEGF-induced activation of c-Src, and also with the sub-
cellular colocalization and interaction between VEGFR-2 and c-Src.
Dependence of VEGF-induced thiol oxidation and activation of c-Src on
NADPH oxidase-derived ROS render downstream activation of PI3K-Akt
redox-sensitive in HCAEC. In this model, VEGFR-2 and/or c-Src act as
endothelial redox-sensors that determine whether downstream PI3K-
Akt signaling pathway should be activated or not.
doi:10.1371/journal.pone.0028454.g005
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buffer, heated at 90uC for 3 min before loading onto SDS gel.
Colocalization of VEGFR-2 with c-Src or EEA1-positive
endosome by immunofluorescence
HCAECwereplatedonfibronectincoated glass-bottom chamber
slides (Lab-TekII, Thermo Scientific) and starvedovernight in0.2%
FBScontainingEBM-2.Cellswerepre-cooledfor30 minoniceand
treated with 10 mg/ml single chain recombinant scFvA7 with E tag
antibody for 1 h on ice with gentle agitation [40,41]. This single
chain antibody to the extracellular domain of human VEGFR-2 is
devoid of biological activity and does not affect basal or VEGF-
stimulatedphosphorylationandinternalizationofVEGFR-2.Before
stimulation, cells were washed with ice-cold 0.2% FBS in EBM-2
medium to remove unbound antibody, and fresh serum-starvation
(0.2%FBSinEBM-2)mediumwasadded.HCAECwerestimulated
with 50 ng/ml VEGF and transferred to 37uC. After incubation
with VEGF, in order to remove the antibody from the cell surface,
cells were placed on ice and acid washed (three washes with ice-cold
50 mM glycine in Ca
2+/Mg
2+ HBSS, pH 2.5, and two washes with
Ca
2+/Mg
2+ HBSS, pH 7.5). Fixation and permeabilization were
carried out in 1% PFA and 0.02% saponin, respectively. Cells were
then labeled with goat anti-EEA1 antibody or anti-c-Src antibody
overnight, followed by chick anti-goat alexa647 (red) secondary
antibody. For the recombinant E-tagged anti–human VEGFR-2,
rabbit anti–E-tag (Abcam) followed by AlexaFluor488-conjugated
(green) donkey anti–rabbit (Invitrogen) were used. Samples were
observed under a fluorescence Nikon Eclipse E800 microscope and
a Spot digital camera. Co-localization was quantified using the
Image J colocalization plugin. Co-localization events were normal-
ized for the number of VEGFR-2-positive compartments. For both
channels, the best-fit lower threshold value was used to remove
background signal using threshold tool and counting one-pixel
dimension particles. Means were taken from five random fields from
each of 3 experiments.
Statistical analysis
All values are presented as mean 6 SEM where appropriate.
Statisticalsignificancebetween two groupswasdetermined byuse of
a paired t-test, and values of p,0.05 were considered significant.
Supporting Information
Figure S1 VEGFR-2 from different species demon-
strates conservation of cys 1201 and cys 1208 in the
cytoplasmic tail.
(TIFF)
Figure S2 VEGF-induced thiol oxidation in PLCc-1 does
not require NADPH oxidase-derived ROS. Cysteinyl
labeling assay to Identify thiol oxidation of PLCc-1 in VEGF-
treated (50 ng/ml for 2 mins) HCAEC lysates using biotinylated
IAP probe. HCAEC were transfected with Scram-si or si-p47
phox
as indicated. After cell lysis in the presence of IAA followed by
DTT treatment and IAP labeling, 1.5 mg biotinylated protein
lysates were subject to immunoprecipitation using Streptavidin-
agarose beads and immunoblotted using anti-PLCc-1 antibody.
(TIF)
Figure S3 Colocalization of internalized VEGFR-2 with
EEA-1-positive early endosome is redox-sensitive.
HCAEC transfected with control (Scram-si) (A) or si-p47
phox (B)
were double labeled for internalized VEGFR-2 (green) and EEA-1
(red). Internalized VEGFR-2 was labeled for immunofluorescence
assay as described in the Legend of Figure 4A and is shown here in
green. EEA-1 positive endosomes were labeled with Alexa-
Fluor647-conjugated secondary antibody and is shown in red.
Nuclei were stained with DAPI (blue). (C) Bar graphs show image
analysis for colocalization events using the NIH Image J plugin as
described in the Legend of Figure 4B. The graphs present the
number of colocalization events normalized for the number of
VEGFR-2–positive compartments. Values are the mean of three
experiments 6 S.E.M., each containing numbers obtained from
five random fields. *p,0.05 was considered statistically significant.
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